Pneumonia Testing Market - Growth Drivers and Challenges
Growth Drivers
-
Automation in diagnostics: The integration of artificial intelligence in health diagnostics tends to reduce the overall treatment duration, which is suitable for augmenting the pneumonia testing market globally. According to an article published by NLM in September 2023, the aspect of machine learning-deep learning algorithm demonstrated a characteristic curve of 95%, along with 77.3% specificity, and 87% of sensitivity. Besides, the utilization of AI systems in healthcare has been suitable for 101 radiologists, showcasing 86.4% sensitivity and 87.5% specificity, thus positively impacting the overall market.
-
Air pollution impact: An increase in pneumonia cases is highly denoted by a surge in air pollution internationally, which has bolstered the pneumonia testing market demand. As per the 2025 WHO report, 99% of the global population breathe air that comprises harmful pollutants, with developing countries suffering the most from high exposures. Besides, the April 2025 NIH report stated that over 6.5 million deaths take place every year, denoting an increase over the past two decades. From vehicle emissions to natural gas, fuel oils, and power generation, especially from coal-based power facilities, are creating increased pollution, which in turn is increasing pneumonia, and hence an increase in the market demand.
-
Expansion in travel medicine: Travelers returning from international destinations are possible carriers of respiratory illness, leading to pneumonia cases, which in turn is driving the pneumonia testing market. As stated in the April 2025 NLM article, 36% infections are caused during travelling, which has resulted in the increased need for travel medicines. Besides, the March 2023 Medscape report indicated that over 1.4 billion travelers have crossed international borders, in comparison to 25 million in previous years, thereby denoting the requirement for travel health clinics, which is positively impacting the market.
X-Ray (including CT-Scan) Sourcing for the Pneumonia Testing Market
X-Ray Import and Export Global Data
|
Countries |
Export |
Import |
|
U.S. |
USD 3.5 million |
USD 33.9 million |
|
Germany |
USD 1.0 million |
USD 11.8 million |
|
Bangladesh |
USD 763,000 |
- |
|
Brazil |
USD 650,000 |
- |
|
Egypt |
USD 603,000 |
- |
|
China |
- |
USD 49.1 million |
|
Japan |
- |
USD 20.1 million |
|
Israel |
- |
USD 3.4 million |
Source: OEC, 2023
Severity Scoring Systems Impacting the Pneumonia Testing Market
CRB65 and CURB65 Scoring Systems Comparison
|
Component |
CRB65 Score (Community Setting) |
CURB65 Score (Hospital Setting) |
|
Confusion |
Abbreviated Mental Test ≤8 or new disorientation |
Same as community |
|
Raised Respiratory Rate |
≥30 breaths/min |
Same as community |
|
Low Blood Pressure |
Diastolic ≤60 mmHg or Systolic <90 mmHg |
Same as community |
|
Age |
≥65 years |
Same as community |
|
Blood Urea Nitrogen (BUN) |
Not applicable |
>7 mmol/L |
|
Total Possible Points |
4 |
5 |
Source: NLM, October 2023
Challenges
-
Increased out-of-pocket expenses: Pneumonia testing costs are creating financial gaps, particularly for underinsured and uninsured patients. For instance, the cash price range for molecular tests denotes a crippling expense for the majority of uninsured patients in America. Besides, the situation is even worse in developing nations, where tests are usually more than a week’s wage. This has resulted in diagnostic and treatment delays, thereby increasing the mortality rate. However, rapid test adoption, partnership with government organizations are probable solutions for this issue, which is suitable for the pneumonia testing market’s upliftment.
-
Disruptions in the supply chain: The pneumonia testing market continues to remain vulnerable to critical bottlenecks in the supply chain that can affect the production process. Severe components, such as specialized plastics, nitrocellulose membranes for rapid tests, and PCR reagents, are sourced from other nations, including the U.S., Germany, and China. Therefore, this concentration has created huge risks, leading to delays in test manufacturers, particularly to produce molecular tests that usually require specialized components from different suppliers, thus causing a hindrance in the market’s growth.
Pneumonia Testing Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
7.2% |
|
Base Year Market Size (2025) |
USD 2.5 billion |
|
Forecast Year Market Size (2035) |
USD 4.6 billion |
|
Regional Scope |
|